Positioning political buying, disclosed 2026-08-18
Options no verdict drawn today, left as found
Ethical passes the values gate
Price186.05 USD
Fair value268.75
Ethical score77.9/100
RatingOPPORTUNITY
Our investment reviews on this name
2026-07-18Read Markup144.28+29.0% to today ✓
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Workday, Inc. holds its Markup at $186.05. Consolidating, no directional conviction, held for 22 days.
As held on the ledger · 2026-09-09
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 22 days
Price at the screen
$186.05
Valuation
37.82 trailing · 14.07 forward price to earnings
Values screen
PASS· score 77.9
Beta
1.08
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
21.14%
Below 33%
Interest-bearing debt is just 21.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
1.29%
Below 33%
Cash held in interest-bearing accounts and securities is 1.3% of assets, under the one-third limit.
Pass
Receivables
21.21%
Below 49%
Money owed to the company is 21.2% of assets, under the 49% limit.
Pass
Revenue purity
3.33%
Below 5%
Only 3.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Conscience Overlay
Conscience flag · Employee campaigns
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Cited in employee-led campaigns for human capital management and enterprise software contracts with entities connected to Israeli operations. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OPPORTUNITY: it trades at roughly a 45% discount to our $268.75 fair value, narrow competitive moat, 12.80% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 44.5% margin of safety to the base estimate.
Third-party analyst targets: 38 covering, consensus Buy. The average target sits +16% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Workday Powers the Quiet Back Office
Picture a multinational firm trying to run payroll and accounts across dozens of countries without the spreadsheets breaking every quarter. Workday sells the cloud tools that keep those wheels turning, and it does so with steady demand from large enterprises that rarely switch providers.
The shares sit at $144.78 against our $200 fair value, a 38 percent margin of safety. Forward earnings trade at just 11.5 times while revenue grows 14 percent a year, margins sit at 9 percent and return on equity reaches 11 percent. The narrow moat and clean ethical screen support the case for a business that looks underpriced relative to its cash flow potential.
Competition remains fierce in enterprise software and the modest growth rate leaves little room for execution slips. A cyclical slowdown in IT budgets could pressure results faster than the current multiple suggests. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
WDAY trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-27Markup$200.01+0.0%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-26Markup$200.01+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-25Markup$200.01+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Markup$200.01+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-23Markup$200.01+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-22Markup$200.01+17.2%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 17.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-21Markup$170.64+0.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-20Markup$170.64+0.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-16Markup$170.64+18.3%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 18.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175.
2026-07-18Markup$144.28+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 46%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (38 analysts) rates it buy, with a mean price target of $175.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
